HTA | EUCOPE AISBL

News - May 10, 2022

PharmaBoardroom Opinion: New EU HTA Procedure – Will it Reduce the Complexity and Burdens for Manufacturers?

This article originally featured in PharmaBoardroom. You can find the original article here. EUCOPE’s Secretary-General Dr. Alexander Natz sees both opportunities and pitfalls with the EU HTA procedure, saying that the next three years will decide the crucial steps and whether the new procedure leads… read more

Access HTA innovation Medicines Patients Regulatory

News - April 6, 2022

The Implications Of The New EU HTA Regulation For Companies

Joint Clinical Assessments Will Become A Key Part Of The New Environment Regulation (EU) 2021/2282 on health technology assessment (HTA) is now in force and will bring important and wide-reaching changes that pharmaceutical companies need to understand. Arguably the most important implication of the regulation… read more

HTA

EUCOPE News by Tag — HTA

PharmaBoardroom Opinion: New EU HTA Procedure – Will it Reduce the Complexity and Burdens for Manufacturers?

The Implications Of The New EU HTA Regulation For Companies